![]() |
Volumn 9, Issue 7, 2001, Pages 1929-1939
|
A strategy for tumor-selective chemotherapy by enzymatic liberation of seco-duocarmycin SA-derivatives from nontoxic prodrugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY CONJUGATE;
CHLORINE;
CI TMI 14;
DUOCARMYCIN DERIVATIVE;
DUOCARMYCIN SA;
GLYCOSIDE;
MONOCLONAL ANTIBODY;
NITROANISIDINE;
PRODRUG;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
ANTIBODY DIRECTED ENZYME PRODRUG THERAPY;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CELL PROLIFERATION;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
LUNG CARCINOMA;
MASS SPECTROMETRY;
PH;
PROTON NUCLEAR MAGNETIC RESONANCE;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIBODIES;
BRONCHIAL NEOPLASMS;
HUMANS;
INDOLES;
MAGNETIC RESONANCE SPECTROSCOPY;
MASS SPECTROMETRY;
PRODRUGS;
PYRROLES;
TUMOR CELLS, CULTURED;
|
EID: 0034945043
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(01)00098-0 Document Type: Article |
Times cited : (39)
|
References (20)
|